Study Identifies Factors That Interfere with Cancer Detection in Liquid Biopsy
Research analyzing cell-free DNA fragmentation patterns in healthy individuals reveals physiological confounders that could improve test accuracy.
Tag: cancer liquid biopsies
All
Latest
All
Latest
Researchers Develop Affordable, Rapid Blood Test for Brain Cancer
A new automated device can diagnose glioblastoma in under an hour using a novel electrokinetic biochip that detects active EGFRs from blood.
All
Latest
Volition Presents New Liquid Biopsy Method for Early-Stage Cancer
VolitionRx detailed a new liquid biopsy cancer-detection method at the annual congress of the European Society for Medical Oncology.
Novel ML Blood Test Detects Cancers with Genome-Wide Mutations in cfDNA Molecules
New blood testing tech combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning.
Read More
DM-Seq Could Lead to Easier Testing, Earlier Cancer Detection
The new DM-Seq technique allows for scientists to profile DNA using very small samples and without damaging the sample.
Read More
New Multi-Cancer Early Detection Data Presented at ASCO 2023
The study’s multi-cancer early detection data show Exai’s RNA- and AI-based platform can detect multiple cancer types at the earliest stages using a single, standard blood sample.
Read More
PDACatch an FDA Breakthrough Device for Pancreatic Cancer Detection
Singlera Genomics’ PDACatch assay is a novel DNA methylation-based liquid biopsy assay for the detection of pancreatic adenocarcinoma in individuals at high risk for the disease.
Read More
Blood-Based Colon Cancer Test Provides Early Detection
Beacon Biomedical released a colon cancer screening test designed to improve access and affordability to CRC screening as a blood draw.
Read More
Blood Biomarkers Predict Neuroendocrine Tumor Response to Radiopharmaceutical Therapy
A simple blood draw can help determine if peptide receptor radionuclide therapy is effective in a patient with neuroendocrine cancer.
Read More
Guardant Health Submits FDA Premarket Approval Application for Colon Cancer Blood Test
Guardant Health submitted the final module of its premarket approval application for a colon cancer screening blood test to the FDA.
Read More
Exai Bio Expands RNA-based Breast Cancer Liquid Biopsy Platform through Collaboration
Exai Bio is collaborating with Quantum Leap Healthcare Collaborative to broaden the use of its novel, RNA-based liquid biopsy platform.
Read More
Rapid Novor’s Multiple Myeloma Monitoring Blood Test Gets CLIA Certification
Rapid Novor obtained the CLIA certification for its EasyM assay for Multiple Myeloma as a laboratory developed test.
Read More
Children’s Hospital LA Develops Liquid Biopsy for Pediatric Tumors
Investigators at Children’s Hospital Los Angeles investigators have developed a liquid biopsy for pediatric solid tumors.
Read More
Biomarker for Brain Cancer Blood Test Identified
Researchers have identified a biomarker that can be used in blood tests to diagnose glioblastoma (GBM), a common type of brain cancer.
Read More
LynxDx Launches Non-invasive Prostate Cancer Screening Solution
LynxDx is introducing a non-invasive, data-driven, urine prostate cancer screening test to guide clinical decisions for patients.
Read More
New Prostate Cancer Blood Test with 94% Accuracy
Researchers at the University of East Anglia helped develop a blood test to detect prostate cancer with greater accuracy than current methods.
Read More
Scientists Develop Device to Detect Brain Tumors Using Urine
Researchers developed a new device to identify a key membrane protein in urine that indicates whether the patient has a brain tumor.
Read More
A Blood Test for Better Prostate Cancer Diagnostics
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read More